News
With global demand for GLP-1-based drugs rising, Indian CDMOs are ramping up peptide capabilities ahead of key patent ...
An investigation has found at least 74 complaints have been made to hospital managers across England in the past 12 months.
A new study suggests that drugs like Ozempic and Mounjaro may reduce dementia risk. Researchers at the University of Galway ...
Novo Nordisk sees solid Q1 results, major GLP-1 growth potential, and limited downside despite guidance cut and rising risks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback